Follow the 그린생명과학 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 그린생명과학 has published 31 insider filings. Market capitalisation: €42.4bn. The latest transaction was reported on 22 June 2026 (Other). Among the most active insiders: 건덕상사. Every trade is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,864 of 29,063 companies
19.1
score / 100
Value
23
Quality
16
FCF yld-1.8%
Earn yld0.2%
EV/EBITDA45.8x
ROE·
Gross mgn6.1%
Net mgn0.3%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Green Life Science es una empresa del sector de la salud y farmacéutico que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones innovadoras en el campo de las ciencias de la vida.